Market Overview:
The global custom antibody market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for monoclonal antibodies and polyclonal antibodies, rising prevalence of chronic diseases, and growing investments in life science research. Based on type, the global custom antibody market is segmented into monoclonal antibodies, polyclonal antibodies, and others. Monoclonal antibodies are expected to account for the largest share of the global custom antibody market in 2018 owing to their high specificity and affinity for a target antigen. Polyclonal antibodies are also expected to witness significant growth during the forecast period due to their low cost and easy production process as compared with monoclonal antibodies. Based on application, the global custom antibody market is segmented into bioScience companies, bioScience research institutions, hospitals & clinics, and others (academic institutes & diagnostic laboratories).
Product Definition:
A custom antibody is a type of antibody that has been designed and created specifically for a particular individual or research project. Custom antibodies can be used for a variety of purposes, including diagnostics, drug development, and basic research. Because they are tailor-made to meet the needs of each individual or project, custom antibodies can be extremely useful in certain situations. They can also be more expensive than commercially available antibodies.
Monoclonal:
Monoclonal antibodies are antibody molecules, which are produced by the immune system to fight against specific targets. These antibodies can bind with a single antigen and neutralize its threat. Monoclonal antibody is different from polyclonal antibodies as they have specificity for a particular target cell or tissue rather than an entire body.
The monoclonal market is expected to grow at a lucrative rate during the forecast period due to technological advancements in genetic engineering.
Polyclonal:
Polyclonal antibodies are made by immunizing animals (mice, rats, etc.) with the antigen of interest. These antibodies are then harvested from the animals and used for immunoassays or to detect antigens in biological fluids such as serum or blood. Polyclonal antibodies can recognize multiple epitopes on a single antigen molecule and can be cross-linked by conjugated toxins or other chemicals.
Application Insights:
The application segment is segregated into bio-science companies, bio-science research institutions, hospitals and others. The hospitals segment held the largest market share in 2017 and this trend is expected to continue over the forecast period. This can be attributed to a rise in number of patients suffering from chronic diseases worldwide. For instance, according to WHO estimates around 1 child in 5 dies before reaching the age of five years globally and about 2 children die every minute due to under-five mortality rate which indicates a huge unmet healthcare need for kid¢â‚¬â„¢s health globally. Therefore, it is anticipated that demand for custom antibodies will grow at lucrative rates over the forecast period owing to rising global healthcare spending along with increasing investments by governments & private investors in R&D sectors across various countries including India, China Japan Brazil etc.
Regional Analysis:
North America dominated the global market in terms of revenue share in 2017. The presence of a large number of biotechnology and biopharmaceutical companies, which are engaged in drug discovery and development, has resulted in high demand for antibodies globally. Moreover, increasing investments by these companies to develop novel therapeutics is expected to drive the regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising healthcare expenditure coupled with growing patient awareness levels regarding advanced treatment options leading towards better medical outcomes at lower costs.
Growth Factors:
- Increasing demand for monoclonal antibodies for research and therapeutic applications
- Growing prevalence of cancer and other diseases that can be treated with monoclonal antibodies
- Rising number of biotech and pharmaceutical companies engaged in the development of custom antibodies
- Advances in antibody engineering technologies that are making it easier to develop custom antibodies
- Growing interest in using custom antibodies for personalized medicine
Scope Of The Report
Report Attributes
Report Details
Report Title
Custom Antibody Market Research Report
By Type
Monoclonal, Polyclonal, Others
By Application
BioScience Companies, BioScience Research Institutions, Hospitals
By Companies
ThermoFisher, GenScript, Abcam, MBS, ROCKLAND, ProSci, Biocompare, Bio-Rad, Covance, Capra Science, Innovagen, LIFE SCIENCE GROUP, Randox, GL Biochem, Abgent
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global Custom Antibody Market Report Segments:
The global Custom Antibody market is segmented on the basis of:
Types
Monoclonal, Polyclonal, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
BioScience Companies, BioScience Research Institutions, Hospitals
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- ThermoFisher
- GenScript
- Abcam
- MBS
- ROCKLAND
- ProSci
- Biocompare
- Bio-Rad
- Covance
- Capra Science
- Innovagen
- LIFE SCIENCE GROUP
- Randox
- GL Biochem
- Abgent
Highlights of The Custom Antibody Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Monoclonal
- Polyclonal
- Others
- By Application:
- BioScience Companies
- BioScience Research Institutions
- Hospitals
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Custom Antibody Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Custom antibody is a type of antibody that has been specifically designed for a particular patient or application.
Some of the key players operating in the custom antibody market are ThermoFisher, GenScript, Abcam, MBS, ROCKLAND, ProSci, Biocompare, Bio-Rad, Covance, Capra Science, Innovagen, LIFE SCIENCE GROUP, Randox, GL Biochem, Abgent.
The custom antibody market is expected to register a CAGR of 10.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Custom Antibody Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Custom Antibody Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Custom Antibody Market - Supply Chain
4.5. Global Custom Antibody Market Forecast
4.5.1. Custom Antibody Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Custom Antibody Market Size (000 Units) and Y-o-Y Growth
4.5.3. Custom Antibody Market Absolute $ Opportunity
5. Global Custom Antibody Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Custom Antibody Market Size and Volume Forecast by Type
5.3.1. Monoclonal
5.3.2. Polyclonal
5.3.3. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Custom Antibody Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Custom Antibody Market Size and Volume Forecast by Application
6.3.1. BioScience Companies
6.3.2. BioScience Research Institutions
6.3.3. Hospitals
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Custom Antibody Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Custom Antibody Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Custom Antibody Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Custom Antibody Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Custom Antibody Demand Share Forecast, 2019-2029
9. North America Custom Antibody Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Custom Antibody Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Custom Antibody Market Size and Volume Forecast by Application
9.4.1. BioScience Companies
9.4.2. BioScience Research Institutions
9.4.3. Hospitals
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Custom Antibody Market Size and Volume Forecast by Type
9.7.1. Monoclonal
9.7.2. Polyclonal
9.7.3. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Custom Antibody Demand Share Forecast, 2019-2029
10. Latin America Custom Antibody Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Custom Antibody Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Custom Antibody Market Size and Volume Forecast by Application
10.4.1. BioScience Companies
10.4.2. BioScience Research Institutions
10.4.3. Hospitals
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Custom Antibody Market Size and Volume Forecast by Type
10.7.1. Monoclonal
10.7.2. Polyclonal
10.7.3. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Custom Antibody Demand Share Forecast, 2019-2029
11. Europe Custom Antibody Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Custom Antibody Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Custom Antibody Market Size and Volume Forecast by Application
11.4.1. BioScience Companies
11.4.2. BioScience Research Institutions
11.4.3. Hospitals
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Custom Antibody Market Size and Volume Forecast by Type
11.7.1. Monoclonal
11.7.2. Polyclonal
11.7.3. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections y Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Custom Antibody Demand Share, 2019-2029
12. Asia Pacific Custom Antibody Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Custom Antibody Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Custom Antibody Market Size and Volume Forecast by Application
12.4.1. BioScience Companies
12.4.2. BioScience Research Institutions
12.4.3. Hospitals
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Custom Antibody Market Size and Volume Forecast by Type
12.7.1. Monoclonal
12.7.2. Polyclonal
12.7.3. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Custom Antibody Demand Share, 2019-2029
13. Middle East & Africa Custom Antibody Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Custom Antibody Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Custom Antibody Market Size and Volume Forecast by Application
13.4.1. BioScience Companies
13.4.2. BioScience Research Institutions
13.4.3. Hospitals
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Custom Antibody Market Size and Volume Forecast by Type
13.7.1. Monoclonal
13.7.2. Polyclonal
13.7.3. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Custom Antibody Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Custom Antibody Market: Market Share Analysis
14.2. Custom Antibody Distributors and Customers
14.3. Custom Antibody Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. ThermoFisher
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. GenScript
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Abcam
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. MBS
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. ROCKLAND
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. ProSci
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Biocompare
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Bio-Rad
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Covance
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Capra Science
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Innovagen
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. LIFE SCIENCE GROUP
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Randox
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. GL Biochem
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Abgent
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook